Association between white matter lesion and clinical symptoms in patients with Parkinson's disease

Du Jing; Wu Tieyu; Yan Sunhong; Xi Chunhua; Wang Kai

doi:10.13406/j.cnki.cyxb.003502

您当前的位置：

首页 >

文章列表页 >

Association between white matter lesion and clinical symptoms in patients with Parkinson's disease

Treatment of movement disorders | 更新时间：2025-10-22

- Association between white matter lesion and clinical symptoms in patients with Parkinson's disease
- Journal of Chongqing Medical University Vol. 49, Issue 5, Pages: 558-562(2024)
- 作者机构：
  
  1.安徽医科大学第一附属医院神经内科,合肥 230022
  2.安徽医科大学第二附属医院神经内科,合肥 230601
  3.安徽医科大学第三附属医院神经内科,合肥 230061
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003502
  CLC： R742.5
- Received：04 January 2024，
  
  Revised：2024-02-07，
  
  Accepted：21 February 2024，
  
  Published：28 May 2024
- 稿件说明：
移动端阅览
杜静,吴铁妤,严孙宏,等.脑白质病变与帕金森病患者临床症状的相关性研究[J].重庆医科大学学报,2024,49(5):558-562.

Du Jing,Wu Tieyu,Yan Sunhong,et al.Association between white matter lesion and clinical symptoms in patients with Parkinson's disease[J].Journal of Chongqing Medical University,2024,49(5):558-562.
杜静,吴铁妤,严孙宏,等.脑白质病变与帕金森病患者临床症状的相关性研究[J].重庆医科大学学报,2024,49(5):558-562. DOI： 10.13406/j.cnki.cyxb.003502.

Du Jing,Wu Tieyu,Yan Sunhong,et al.Association between white matter lesion and clinical symptoms in patients with Parkinson's disease[J].Journal of Chongqing Medical University,2024,49(5):558-562. DOI： 10.13406/j.cnki.cyxb.003502.

摘要

目的

探讨脑白质病变（white matter lesions，WML）对帕金森病（Parkinson’s disease，PD）患者运动症状、认知功能和情绪的影响。

方法

纳入2018年1月至2023年12月就诊于安徽医科大学第二附属医院神经内科PD患者123例，应用年龄相关的白质改变（age‐related white matter changes，ARWMC）量表评估患者头颅MRI影像学的脑白质病变程度，根据评分结果将患者分为轻度WML组（46例），中重度WML组（77例）；使用帕金森病统一评定量表第三部分、Hoehn & Yahr（H‐Y）分级量表评定运动症状及疾病严重程度，简易精神状态检查（mini‐mental state examination，MMSE）评估PD的认知功能，汉密尔顿抑郁量表，汉密尔顿焦虑量表评定情绪状态，Barthel指数评定患者日常生活功能状态。比较两组患者的运动症状、认知及情绪评分等差异，应用Logistic回归分析PD患者的WML与临床症状的关系。

结果

中重度WML组的高血压发生率（41.6% vs. 23.9%，

0.05）高于轻度WML组。中重度WML组的H‐Y分级高于轻度WML组［2.5（1.5，3.0） vs. 2.0（1.5，2.5），

0.05］，UPDRS‐Ⅲ评分高于轻度WML组［（34.0±16.5） vs. （24.09±11.04），

0.01］。此外，中重度WML组的MMSE评分低于轻度WML组［24.0（18.5，27.0） vs. 26.0（23.8，27.0），

0.01］，Barthel得分亦低于轻度WML组［（77.4±17.4） vs. （83.5±11.7），

0.05］，差异有统计学意义。相关分析显示，ARWMC总分与HY及UPDRS‐Ⅲ得分呈正相关，与年龄亦呈正相关。ARWMC总分与MMSE得分及Barthel评分呈负相关。Logistic回归分析显示，重度WML损害与认知障碍有相关性（回归系数

=1.072，95%CI=1.078~7.918，

=0.035）。

结论

WML与PD运动障碍、认知功能损害及生活质量下降相关。

Abstract

Objective

To investigate the influence of cerebral white matter lesion（WML） on motor symptoms，cognitive function，and mood in patients with Parkinson's disease（PD）.

Methods

A total of 123 patients with PD who visited the Department of Neurology of the Second Affiliated Hospital of Anhui Medical University from January 2018 to December 2023 were included. Age‐related White Matter Changes（ARWMC） scale was used to evaluate the degree of cerebral WML on cranial MRI imaging，according to the score of the scale，the patients were divided into mild WML group with 46 patients and moderate‐to‐severe WML group with 77 patients. The Unified Parkinson's Disease Rating Scale Part Ⅲ（UPDRS‐Ⅲ） and Hoehn‐Yahr（H‐Y） Rating Scale were used to assess motor symptoms and disease severity； Mini‐Mental State Examination（MMSE） was used to assess cognitive function in PD； Hamilton Depression Scale and Hamilton Anxiety Scale were used to assess the emotion of PD patients； Barthel Index was used to assess the activities of daily living. The scores of motor symptoms，cognitive function，and mood in patients were compared between the two groups， and the relationship between WML and PD patients symptoms was analyzed by Logistic regression.

Results

The moderate‐to‐severe WML group had a significantly higher incidence rate of hypertension than the mild WML group（41.6% vs. 23.9%，

0.05）. Compared with the mild WML group，the moderate‐to‐severe WML group had significantly higher H‐Y stage［2.5（1.5，3.0） vs. 2.0（1.5，2.5），

0.05］ and UPDRS‐Ⅲ score（34.0±16.5 vs. 24.09±11.04，

0.01）. Compared with the mild WML group，the moderate‐to‐severe WML group had significantly lower MMSE score［24.0（18.5，27.0） vs. 26.0（23.8，27.0），

0.01］ and Barthel Index［（77.4±17.4） vs.（83.5±11.7），

0.05］. The correlation analysis showed that total ARWMC score was positively correlated with H‐Y stage，UPDRS‐Ⅲ score，and age，while it was negatively correlated with MMSE score and Barthel Index. The logistic regression analysis showed a significant association between severe WML impairment and cognitive impairment（

=1.072，95% confidence interval：1.078~7.918，

=0.035）.

Conclusion

WML is associated with dyskinesia，cognitive impairment，and reduction in quality of life in PD.

关键词

Keywords

references

Dorsey ER ， Bloem BR . The parkinson pandemic-a call to action [J ] . JAMA Neurol ， 2018 ， 75 （ 1 ）： 9 - 10 ．

Schmidt R ， Ropele S ， Enzinger C ， et al . White matter lesion progression，brain atrophy，and cognitive decline：the Austrian stroke prevention study [J ] . Ann Neurol ， 2005 ， 58 （ 4 ）： 610 - 616 ．

Lampe L ， Kharabian-Masouleh S ， Kynast J ， et al . Lesion location matters：the relationships between white matter hyperintensities on cognition in the healthy elderly [J ] . J Cereb Blood Flow Metab ， 2019 ， 39 （ 1 ）： 36 - 43 ．

Erten-Lyons D ， Woltjer R ， Kaye J ， et al . Neuropathologic basis of white matter hyperintensity accumulation with advanced age [J ] . Neurology ， 2013 ， 81 （ 11 ）： 977 - 983 ．

彭泽艳，董舒阳，周华东 . 脑白质病变与老年帕金森病患者运动功能障碍的相关性研究 [J ] . 中华全科医学， 2018 ， 16 （ 5 ）： 693 - 696 ．

Peng ZY ， Dong SY ， Zhou HD . Association between white matter lesions and motor impairment in patients with Parkinson's disease [J ] . Chin J Gen Pract ， 2018 ， 16 （ 5 ）： 693 - 696 ．

Ji GJ ， Ren CP ， Li Y ， et al . Regional and network properties of white matter function in Parkinson's disease [J ] . Hum Brain Mapp ， 2019 ， 40 （ 4 ）： 1253 - 1263 ．

Scamarcia PG ， Agosta F ， Spinelli EG ， et al . Longitudinal white matter damage evolution in Parkinson's disease [J ] . Mov Disord ， 2022 ， 37 （ 2 ）： 315 - 324 ．

Herman T ， Rosenberg-Katz K ， Jacob Y ， et al . White matter hyperintensities in Parkinson's disease：do they explain the disparity between the postural instability gait difficulty and tremor dominant subtypes? [J ] . PLoS One ， 2013 ， 8 （ 1 ）： e55193 ．

de Schipper LJ ， Hafkemeijer A ， Bouts MJRJ ， et al . Age- and disease-related cerebral white matter changes in patients with Parkinson's disease [J ] . Neurobiol Aging ， 2019 ， 80 ： 203 - 209 ．

Lane CA ， Barnes J ， Nicholas JM ， et al . Associations between blood pressure across adulthood and late-life brain structure and pathology in the neuroscience substudy of the 1946 British birth cohort（Insight 46）：an epidemiological study [J ] . Lancet Neurol ， 2019 ， 18 （ 10 ）： 942 - 952 ．

de Leeuw FE ， de Groot JC ， Oudkerk M ， et al . Hypertension and cerebral white matter lesions in a prospective cohort study [J ] . Brain ， 2002 ， 125 （ Pt 4 ）： 765 - 772 ．

Petrea RE ， Pinheiro A ， Demissie S ， et al . Hypertension trends and white matter brain injury in the offspring framingham heart study cohort [J ] . Hypertension ， 2024 ， 81 （ 1 ）： 87 - 95 ．

Zhang BY ， Wang YZ ， Wang B ， et al . MRI-based investigation of association between cerebrovascular structural alteration and white matter hyperintensity induced by high blood pressure [J ] . J Magn Reson Imaging ， 2021 ， 54 （ 5 ）： 1516 - 1526 ．

Williams-Gray CH ， Foltynie T ， Brayne CE ， et al . Evolution of cognitive dysfunction in an incident Parkinson's disease cohort [J ] . Brain ， 2007 ， 130 （ Pt 7 ）： 1787 - 1798 ．

Schwartz RS ， Halliday GM ， Soh D ， et al . Impact of small vessel disease on severity of motor and cognitive impairment in Parkinson's disease [J ] . J Clin Neurosci ， 2018 ， 58 ： 70 - 74 ．

Tsai HH ， Tsai LK ， Lo YL ， et al . Amyloid related cerebral microbleed and plasma Aβ40 are associated with cognitive decline in Parkinson's disease [J ] . Sci Rep ， 2021 ， 11 （ 1 ）： 7115 ．

Hou MM ， Hou XJ ， Qiu YQ ， et al . Characteristics of cognitive impairment and their relationship with total cerebral small vascular disease score in Parkinson's disease [J ] . Front Aging Neurosci ， 2022 ， 14 ： 884506 ．

Zhang ZW ， Li SS ， Wang SM . Application of periventricular white matter hyperintensities combined with homocysteine into predicting mild cognitive impairment in Parkinson's disease [J ] . Int J Gen Med ， 2023 ， 16 ： 785 - 792 ．

Petrou M ， Kotagal V ， Bohnen NI . An update on brain imaging in parkinsonian dementia [J ] . Imaging Med ， 2012 ， 4 （ 2 ）： 201 - 213 ．

王义精，高莉娜，郝淼淼，等 . 帕金森病扩大的血管周围间隙增加及类淋巴系统功能障碍的机制研究 [J ] . 中国神经精神疾病杂志， 2022 ， 48 （ 1 ）： 21 - 27 .

Wang YJ ， Gao LN ， Hao MM ， et al . The enlarged perivascular space increased and the mechanism of dysfunction of glymphatic system in Parkinson disease [J ] . Chin J Nerv Ment Dis ， 2022 ， 48 （ 1 ）： 21 - 27 ．

Rasmussen MK ， Mestre H ， Nedergaard M . The glymphatic pathway in neurological disorders [J ] . Lancet Neurol ， 2018 ， 17 （ 11 ）： 1016 - 1024 ．

Moccia M ， Tedeschi E ， Ugga L ， et al . White matter changes and the development of motor phenotypes in de novo Parkinson's Disease [J ] . J Neurol Sci ， 2016 ， 367 ： 215 - 219 ．

Malek N ， Lawton MA ， Swallow DM ， et al . Vascular disease and vascular risk factors in relation to motor features and cognition in early Parkinson's disease [J ] . Mov Disord ， 2016 ， 31 （ 10 ）： 1518 - 1526 ．

Jeong SH ， Lee HS ， Jung JH ， et al . White matter hyperintensities，dopamine loss，and motor deficits in de novo Parkinson's disease [J ] . Mov Disord ， 2021 ， 36 （ 6 ）： 1411 - 1419 ．

Chung SJ ， Yoo HS ， Shin NY ， et al . Perivascular spaces in the basal Ganglia and long-term motor prognosis in newly diagnosed parkinson disease [J ] . Neurology ， 2021 ， 96 （ 16 ）： e2121 - e2131 ．

Hall JM ， Shine JM ， Ehgoetz Martens KA ， et al . Alterations in white matter network topology contribute to freezing of gait in Parkinson's disease [J ] . J Neurol ， 2018 ， 265 （ 6 ）： 1353 - 1364 .

Song IU ， Kim YD ， Cho HJ ， et al . The effects of silent cerebral ischemic lesions on the prognosis of idiopathic Parkinson's disease [J ] . Parkinson's Relat Disord ， 2013 ， 19 （ 8 ）: 761 - 763

Carvalho de Abreu DC ， Pieruccini-Faria F ， Sarquis-Adamson Y ， et al . White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative [J ] . Eur J Neurol ， 2023 ， 30 （ 4 ）： 920 - 933 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Advances in invasive neuromodulation therapy for gait disturbance in Parkinson's disease

Research advances in pharmacotherapy for Parkinson's disease

Correlation of serum thyroxine and Apelin with cognitive impairment in patients with cerebral small vessel disease

Analysis of risk factors for early cognitive impairment after endovascular treatment for mild aneurysmal subarachnoid hemorrhage

Correlation between cognitive impairment after stroke and compensatory degree of leptomeningeal collaterals and intravenous thrombolytic therapy

Related Author

Li Dianyou

Zeng Zhitong

Sun Bomin

Huang Peng

Chen Shengdi

Wang Gang

Chen Xianwen

Fan Zhen

Related Institution

Department of Neurosurgery，Ruijin Hospital，Shanghai Jiao Tong University School of Medicine

Department of Neurology,Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Department of Geriatrics，Sichuan Provincial People's Hospital，Sichuan Academy of Medical Sciences

Department of Neurology，Huadong Hospital Affiliated to Fudan University

Department of Neurology， Shihezi People’s Hospital

⁰